![]() |
Volumn 40, Issue 5, 2005, Pages 505-519
|
Development of a prostaglandin D2 receptor antagonist: Discovery of a new chemical lead
|
Author keywords
Antagonist; DP receptor; Prostaglandin
|
Indexed keywords
(5 HYDROXY 2 METHYL 1H INDOL 3 YL)ACETIC ACID;
2 BUTOXY N' (ETHYLIDENE) N (4 METHOXYPHENYL)BENZOHYDRAZIDE;
2 METHYLINDOLE 4 ACETIC ACID DERIVATIVE;
3 BUTOXY N' (ETHYLIDENE) N (4 METHOXYPHENYL)BENZOHYDRAZIDE;
4 BUTOXY N (4 CHLOROPHENYL) N' (ETHYLIDENE)BENZOHYDRAZIDE;
4 BUTOXY N' (ETHYLIDENE) N (4 ISOPROPYLPHENYL)BENZOHYDRAZIDE;
4 BUTOXY N' (ETHYLIDENE) N (4 METHOXYPHENYL)BENZOHYDRAZIDE;
4 BUTOXY N' (ETHYLIDENE) N (4 METHYLPHENYL)BENZOHYDRAZIDE;
4 BUTOXY N' (ETHYLIDENE) N PHENYLBENZOHYDRAZIDE;
4 ETHOXY N' (ETHYLIDENE) N (4 FLUOROPHENYL)BENZOHYDRAZIDE;
4 ETHOXY N' (ETHYLIDENE) N (4 METHOXYPHENYL)BENZOHYDRAZIDE;
4 METHOXY N' (ETHYLIDENE) N (4 METHOXYPHENYL)BENZOHYDRAZIDE;
[1 (2 BUTOXYBENZOYL) 5 METHOXY 2 METHYL 1H INDOL 3 YL]ACETIC ACID;
[1 (3 BUTOXYBENZOYL) 5 METHOXY 2 METHYL 1H INDOL 3 YL]ACETIC ACID;
[1 (4 BUTOXYBENZOYL) 2 METHYL 1H INDOL 3 YL]ACETIC ACID;
[1 (4 BUTOXYBENZOYL) 2,5 DIMETHYL 1H INDOL 3 YL]ACETIC ACID;
[1 (4 BUTOXYBENZOYL) 5 ISOPROPYL 2 METHYL 1H INDOL 3 YL]ACETIC ACID;
[1 (4 BUTOXYBENZOYL) 5 METHOXY 2 METHYL 1H INDOL 3 YL]ACETIC ACID;
[1 (4 ETHOXYBENZOYL) 5 METHOXY 2 METHYL 1H INDOL 3 YL]ACETIC ACID;
[1 (4 METHOXYBENZOYL) 5 METHOXY 2 METHYL 1H INDOL 3 YL]ACETIC ACID;
[1 [4 (HEPTYLOXY)BENZOYL] 5 METHOXY 2 METHYL 1H INDOL 3 YL]ACETIC ACID;
[1 [4 (HEXYLOXY)BENZOYL] 5 METHOXY 2 METHYL 1H INDOL 3 YL]ACETIC ACID;
[5 FLUORO 2 METHYL 1 (4 PENTYLBENZOYL) 1H INDOL 3 YL]ACETIC ACID;
[5 METHOXY 2 METHYL 1 (4 PENTYLBENZOYL) 1H INDOL 3 YL]ACETIC ACID;
[5 METHOXY 2 METHYL 1 (4 PROPOXYBENZOYL) 1H INDOL 3 YL]ACETIC ACID;
[5 METHOXY 2 METHYL 1 [4 (PENTYLOXY)BENZOYL] 1H INDOL 3 YL]ACETIC ACID;
ACETIC ACID DERIVATIVE;
CYCLIC AMP;
INDOMETACIN;
INDOMETACIN DERIVATIVE;
N (4 BUTOXY)BENZOYL 2 METHYLINDOLE 4 ACETIC ACID;
N' (ETHYLIDENE) N (4 HEPTYLOXY) N (4 METHOXYPHENYL)BENZOHYDRAZIDE;
N' (ETHYLIDENE) N (4 HEXYLOXY) N (4 METHOXYPHENYL)BENZOHYDRAZIDE;
N' (ETHYLIDENE) N (4 METHOXYPHENYL) 4 PROPOXYBENZOHYDRAZIDE;
N' (ETHYLIDENE) N (4 METHOXYPHENYL)4 (PENTYLOXY)BENZOHYDRAZIDE;
N' (ETHYLIDENE) N (4 METHOXYPHENYL)4 PENTYLBENZOHYDRAZIDE;
PROSTAGLANDIN D2 RECEPTOR;
PROSTAGLANDIN RECEPTOR;
PROSTAGLANDIN RECEPTOR BLOCKING AGENT;
UNCLASSIFIED DRUG;
DRUG DERIVATIVE;
IMMUNOGLOBULIN RECEPTOR;
INDOLEACETIC ACID DERIVATIVE;
ANIMAL EXPERIMENT;
ARTICLE;
CONTROLLED STUDY;
DRUG RECEPTOR BINDING;
DRUG SYNTHESIS;
IN VITRO STUDY;
MALE;
NONHUMAN;
PHARMACOLOGICAL BLOCKING;
RAT;
RECEPTOR AFFINITY;
RECEPTOR BLOCKING;
SINGLE DRUG DOSE;
STRUCTURE ACTIVITY RELATION;
ANIMAL;
AREA UNDER THE CURVE;
BINDING COMPETITION;
CHEMISTRY;
CHO CELL;
DRUG ANTAGONISM;
HALF LIFE TIME;
HAMSTER;
MASS SPECTROMETRY;
METABOLISM;
MOUSE;
NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY;
PHYSIOLOGY;
SYNTHESIS;
ANIMALS;
AREA UNDER CURVE;
BINDING, COMPETITIVE;
CHO CELLS;
CRICETINAE;
CYCLIC AMP;
HALF-LIFE;
INDOLEACETIC ACIDS;
INDOMETHACIN;
MAGNETIC RESONANCE SPECTROSCOPY;
MALE;
MICE;
RATS;
RECEPTORS, IMMUNOLOGIC;
RECEPTORS, PROSTAGLANDIN;
SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;
STRUCTURE-ACTIVITY RELATIONSHIP;
|
EID: 21044439801
PISSN: 02235234
EISSN: None
Source Type: Journal
DOI: 10.1016/j.ejmech.2004.11.011 Document Type: Article |
Times cited : (19)
|
References (27)
|